Latest Morpholines Stories
Phase III data reported at ESMO 2012 New trial data showing improvements in the treatment of esophageal and gastrointestinal cancers were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. Phase III, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy The first phase III trial to address the need for second-line treatments in esophageal cancer shows that...
- Clothing, especially sumptuous clothing; equipment; outfit.
- To cover with a caparison, as a horse.
- To dress sumptuously; adorn with rich dress.